澳大利亚昆士兰理工大学2020年招聘博士后（临床基因组学）

Job Description

The classification for this position is Academic Level E (LEVE). An attractive remuneration package will be negotiated with the successful applicant.

Fixed-term, full-time basis for three (3) years; with the potential to extend at least another two (2) years.

Position Title:Professor of Clinical Genomics

Vacancy Reference No:20304

Closing Date:22 June 2020

Organisational Area:Institute of Health and Biomedical Innovation (IHBI)

Campus:The position will primarily be located within the Translational Research Institute (TRI) at the Princess Alexandra Hospital (PAH)

RemunerationThe classification for this position is Academic Level E (LEVE). An attractive remuneration package will be negotiated with the successful applicant.

Status:Fixed-term, full-time basis for three (3) years; with the potential to extend at least another two (2) years.

Contact:Professor Lyn Griffiths Executive Director +61 7 3138 1584

HR Contact:Human Resources +61 7 3138 4104

About this Position:

The Queensland University of Technology and the Princess Alexandra Hospital are seeking an outstanding researcher with expertise in Genomics. QUT is a highly successful, energetic and innovative university and we’re backing our aspirations with significant investment in people, state-of-the art infrastructure and collaborative work environments.

In collaboration we are seeking an international leader, whose outstanding research will advance the University and the hospital’s national and international leadership in the area of Clinical Genomics.

Your commitment and engagement will promote development and collaboration in this field across the University, the hospital and the Translational Research Institute, as well as with our external partners, to enable excellence in research outputs that have translational impact.

As a significant Genomics researcher you will bring research strength and leadership to our Genomics capabilities, building capacity in research and expertise across multiple Faculties, engaging with the broader academic and clinical profession, and working with industry and key stakeholders to promote and enhance the national and international profile of our Genomics research.

To be successful you will need:

An outstanding record of academic distinction in your discipline

Evidence of an aspirational leadership style that promotes a culture of engagement, collaboration, commitment and performance.

Demonstrated ability to consistently secure research funding from national and international competitive agencies.

Demonstrated ability to forge meaningful external relationships with relevant stakeholders.

PhD in a related discipline with extensive research experience and track record in your field.

Professor of Clinical Genomics We seek to appoint a research leader in the discipline of Clinical Genomics, Diagnostic Genomics, or Genetic Pathology with responsibility for leading the NATA-accredited Australian Translational Genomics Centre (ATGC) which is implementing genomic annotation in frontline diagnosis and patient management and undertaking cancer genomic discovery research.

The position will help to establish a world-leading research centre in Genomics and will leverage the specialised diagnostic laboratory, facilities and platforms, located within the Translational Research Institute at Princess Alexandra Hospital (PAH) as one of our key distributed sites under the Institute of Health and Biomedical Innovation (IHBI) – QUT.

The successful candidate will be expected to have clinical and or scientific expertise in genomics and preferably will have experience leading an accredited diagnostics laboratory. They will also be required to demonstrate an interdisciplinary approach to addressing critical clinical challenges, demonstrate leadership of independent research and the capacity to obtain external grant funding to support their research. Prospectively, the applicant will be required to lead a genomics research team and take advantage of funding opportunities from national and international funding bodies, health services, and industry linkages.